| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with epigallocatechin gallate] results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:22742579 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:1342674 | 6480464 | [Acetylcarnitine co-treated with Thioctic Acid] results in increased expression of PPARGC1A protein | CTD | PMID:20414966 |
| (R)-lipoic acid | increases expression | ISO | RGD:1342674 | 6480464 | Thioctic Acid results in increased expression of PPARGC1A protein | CTD | PMID:20414966 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:1332548 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA]; more ... | CTD | PMID:16513826 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | Norepinephrine inhibits the reaction [Testosterone results in decreased expression of PPARGC1A mRNA] | CTD | PMID:16954335 |
| (R)-noradrenaline | increases expression | ISO | RGD:1332548 | 6480464 | Norepinephrine results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 |
| 1,4-dithiothreitol | increases expression | ISO | RGD:1342674 | 6480464 | Dithiothreitol results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| 11-deoxycorticosterone | increases expression | ISO | RGD:1342674 | 6480464 | Desoxycorticosterone results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1342674 | 6480464 | Ethinyl Estradiol results in decreased expression of PPARGC1A mRNA | CTD | PMID:18936297 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1342674 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of PPARGC1A mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| 17beta-estradiol | increases expression | ISO | RGD:1342674 | 6480464 | Estradiol results in increased expression of PPARGC1A mRNA | CTD | PMID:21632981 |
| 1D-myo-inositol 1-phosphate | increases expression | ISO | RGD:1342674 | 6480464 | inositol 1-phosphate results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| 1H-pyrazole | decreases expression | ISO | RGD:1332548 | 6480464 | pyrazole results in decreased expression of PPARGC1A mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1342674 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARGC1A mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1332548 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPARGC1A mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1342674 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARGC1A mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPARGC1A mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1332548 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPARGC1A mRNA | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1332548 | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PPARGC1A mRNA]; more ... | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1342674 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPARGC1A mRNA | CTD | PMID:22298810 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1342674 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PPARGC1A protein; more ... | CTD | PMID:20165829 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:1342674 | 6480464 | Glucosamine results in decreased expression of PPARGC1A mRNA; more ... | CTD | PMID:20165829 |
| 2-butoxyethanol | increases expression | ISO | RGD:1332548 | 6480464 | n-butoxyethanol results in increased expression of PPARGC1A mRNA | CTD | PMID:19812364 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:1332548 | 6480464 | Cyclic AMP promotes the reaction [PPARGC1A protein binds to CYP2A5 promoter] | CTD | PMID:18602936 |
| 3',5'-cyclic AMP | increases expression | ISO | RGD:1332548 | 6480464 | Cyclic AMP results in increased expression of PPARGC1A mRNA | CTD | PMID:18602936 PMID:22117073 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:1332548 | 6480464 | PPARGC1A mutant form inhibits the reaction [Cyclic AMP results in decreased expression of IL15RA mRNA]; more ... | CTD | PMID:22117073 |
| 3',5'-cyclic AMP | increases expression | ISO | RGD:1332548 | 6480464 | Cyclic AMP results in increased expression of PPARGC1A mRNA | CTD | PMID:18602936 |
| 4-phenylbutyric acid | multiple interactions | ISO | RGD:1342674 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [AICA ribonucleotide results in increased expression of PPARGC1A mRNA] | CTD | PMID:20438809 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases expression | EXP | | 6480464 | AICA ribonucleotide results in increased expression of PPARGC1A mRNA | CTD | PMID:20438809 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:1332548 | 6480464 | AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein] | CTD | PMID:23090186 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:1342674 | 6480464 | alitretinoin results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:1332548 | 6480464 | alitretinoin results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:1332548 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [alitretinoin results in increased expression of PPARGC1A mRNA]; more ... | CTD | PMID:16513826 |
| acarbose | affects response to substance | ISO | RGD:1342674 | 6480464 | PPARGC1A protein polymorphism affects the susceptibility to Acarbose | CTD | PMID:15592662 |
| adenosine | increases expression | ISO | RGD:1342674 | 6480464 | Adenosine results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| afimoxifene | multiple interactions | ISO | RGD:1342674 | 6480464 | 4-hydroxytamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein] | CTD | PMID:16889744 |
| aflatoxin B1 | affects expression | ISO | RGD:1342674 | 6480464 | Aflatoxin B1 affects the expression of PPARGC1A protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:1342674 | 6480464 | Aflatoxin B1 results in decreased expression of PPARGC1A mRNA | CTD | PMID:21632981 PMID:22100608 |
| albuterol | increases expression | ISO | RGD:1332548 | 6480464 | Albuterol results in increased expression of PPARGC1A mRNA | CTD | PMID:17446185 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1342674 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PPARGC1A protein; more ... | CTD | PMID:20165829 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:1342674 | 6480464 | Glucosamine results in decreased expression of PPARGC1A mRNA; more ... | CTD | PMID:20165829 |
| aldosterone | increases expression | EXP | | 6480464 | Aldosterone results in increased expression of PPARGC1A mRNA | CTD | PMID:19808358 |
| all-trans-retinal | increases expression | ISO | RGD:1342674 | 6480464 | Retinaldehyde results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1332548 | 6480464 | Tretinoin results in increased expression of PPARGC1A mRNA | CTD | PMID:16840543 |
| all-trans-retinol | multiple interactions | ISO | RGD:1332548 | 6480464 | Vitamin A affects the reaction [PPARGC1A protein binds to PCK1 promoter] | CTD | PMID:16317119 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PPARGC1A mRNA | CTD | PMID:16483693 |
| AMP | increases expression | ISO | RGD:1342674 | 6480464 | Adenosine Monophosphate results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| arsenic atom | increases expression | ISO | RGD:1342674 | 6480464 | Arsenic results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:21514422 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1342674 | 6480464 | Benzo(a)pyrene results in decreased expression of PPARGC1A mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1342674 | 6480464 | Benzo(a)pyrene results in decreased expression of PPARGC1A mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1332548 | 6480464 | Benzo(a)pyrene results in decreased expression of PPARGC1A mRNA | CTD | PMID:19770486 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1342674 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PPARGC1A protein; more ... | CTD | PMID:20165829 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20165829 |
| beta-D-glucosamine | decreases expression | ISO | RGD:1342674 | 6480464 | Glucosamine results in decreased expression of PPARGC1A mRNA; more ... | CTD | PMID:20165829 |
| bezafibrate | increases expression | ISO | RGD:1332548 | 6480464 | Bezafibrate results in increased expression of PPARGC1A mRNA | CTD | PMID:17275789 |
| biotin | increases expression | ISO | RGD:1342674 | 6480464 | Biotin results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of PPARGC1A mRNA | CTD | PMID:22672789 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of PPARGC1A mRNA | CTD | PMID:19167457 |
| cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of PPARGC1A promoter | CTD | PMID:22457795 |
| capric acid | increases expression | ISO | RGD:1342674 | 6480464 | decanoic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| capsaicin | increases expression | ISO | RGD:1332548 | 6480464 | Capsaicin results in increased expression of PPARGC1A mRNA | CTD | PMID:19798065 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin promotes the reaction [Dietary Fats results in increased expression of PPARGC1A mRNA] | CTD | PMID:20359164 |
| carbon monoxide | increases expression | ISO | RGD:1332548 | 6480464 | Carbon Monoxide results in increased expression of PPARGC1A mRNA | CTD | PMID:17179207 |
| carbon monoxide | increases expression | EXP | | 6480464 | Carbon Monoxide results in increased expression of PPARGC1A protein | CTD | PMID:17179207 |
| carbon monoxide | multiple interactions | EXP | | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein]; more ... | CTD | PMID:17179207 |
| carvedilol | increases expression | EXP | | 6480464 | carvedilol results in increased expression of PPARGC1A mRNA | CTD | PMID:18971572 |
| chloroprene | increases expression | ISO | RGD:1332548 | 6480464 | Chloroprene results in increased expression of PPARGC1A mRNA | CTD | PMID:23125180 |
| choline | increases expression | ISO | RGD:1342674 | 6480464 | Choline results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| ciglitazone | increases expression | ISO | RGD:1332548 | 6480464 | ciglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 |
| ciglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | PPARG protein promotes the reaction [ciglitazone results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1332548 | 6480464 | Ciguatoxins affects the expression of PPARGC1A mRNA | CTD | PMID:18353800 |
| clenbuterol | increases expression | ISO | RGD:1332548 | 6480464 | Clenbuterol results in increased expression of PPARGC1A mRNA | CTD | PMID:17446185 |
| clenbuterol | increases expression | EXP | | 6480464 | Clenbuterol results in increased expression of PPARGC1A mRNA | CTD | PMID:17446185 |
| clenbuterol | multiple interactions | ISO | RGD:1332548 | 6480464 | Propranolol inhibits the reaction [Clenbuterol results in increased expression of PPARGC1A mRNA] | CTD | PMID:17446185 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of PPARGC1A protein | CTD | PMID:22982409 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PPARGC1A mRNA | CTD | PMID:22465980 |
| copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:18993053 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PPARGC1A mRNA | CTD | PMID:22465980 |
| copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:18993053 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1342674 | 6480464 | Copper Sulfate results in decreased expression of PPARGC1A mRNA | CTD | PMID:19549813 |
| cortisone | increases expression | ISO | RGD:1342674 | 6480464 | Cortisone results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| creatine | increases expression | ISO | RGD:1342674 | 6480464 | Creatine results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| crocidolite asbestos | affects expression | ISO | RGD:1342674 | 6480464 | Asbestos, Crocidolite affects the expression of PPARGC1A mRNA | CTD | PMID:17331233 |
| cyclosporin A | decreases expression | ISO | RGD:1342674 | 6480464 | Cyclosporine results in decreased expression of PPARGC1A mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1332548 | 6480464 | Cyclosporine results in decreased expression of PPARGC1A mRNA | CTD | PMID:19770486 |
| D-glucose | increases acetylation | ISO | RGD:1342674 | 6480464 | Glucose results in increased acetylation of PPARGC1A protein | CTD | PMID:19071085 |
| D-glucose | decreases expression | ISO | RGD:1332548 | 6480464 | Glucose results in decreased expression of PPARGC1A protein | CTD | PMID:23090186 |
| D-glucose | multiple interactions | ISO | RGD:1332548 | 6480464 | AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; more ... | CTD | PMID:23090186 |
| D-glucose | multiple interactions | ISO | RGD:1342674 | 6480464 | Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA] | CTD | PMID:17855661 |
| D-glucose | decreases expression | ISO | RGD:1342674 | 6480464 | Glucose deficiency results in decreased expression of PPARGC1A mRNA | CTD | PMID:17855661 |
| D-glucose | multiple interactions | ISO | RGD:1342674 | 6480464 | [Pyruvic Acid co-treated with Glucose] results in decreased acetylation of PPARGC1A protein | CTD | PMID:19071085 |
| D-glucurono-6,3-lactone | increases expression | ISO | RGD:1342674 | 6480464 | glucuronolactone results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| dexamethasone | increases expression | ISO | RGD:1342674 | 6480464 | Dexamethasone results in increased expression of PPARGC1A mRNA | CTD | PMID:19022236 |
| dexamethasone | increases expression | ISO | RGD:1342674 | 6480464 | Dexamethasone results in increased expression of PPARGC1A mRNA | CTD | PMID:19022236 more ... |
| dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PPARGC1A protein] | CTD | PMID:21094144 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of PPARGC1A mRNA | CTD | PMID:18972406 |
| dexamethasone | multiple interactions | EXP | | 6480464 | INS protein inhibits the reaction [Dexamethasone results in increased expression of PPARGC1A mRNA] | CTD | PMID:18972406 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of PPARGC1A protein | CTD | PMID:21094144 |
| diarsenic trioxide | increases expression | ISO | RGD:1342674 | 6480464 | arsenic trioxide results in increased expression of PPARGC1A mRNA | CTD | PMID:20458559 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PPARGC1A mRNA | CTD | PMID:19808358 |
| dibutyl phthalate | increases expression | ISO | RGD:1332548 | 6480464 | Dibutyl Phthalate results in increased expression of PPARGC1A mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1332548 | 6480464 | Dibutyl Phthalate results in increased expression of PPARGC1A mRNA | CTD | PMID:17361019 PMID:21266533 |
| dihydrofolic acid | increases expression | ISO | RGD:1342674 | 6480464 | dihydrofolate results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| dioxygen | decreases expression | ISO | RGD:1332548 | 6480464 | Oxygen deficiency results in decreased expression of PPARGC1A mRNA; more ... | CTD | PMID:21113404 |
| dioxygen | multiple interactions | ISO | RGD:1332548 | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A mRNA] | CTD | PMID:21113404 |
| enalapril | increases expression | EXP | | 6480464 | Enalapril results in increased expression of PPARGC1A mRNA | CTD | PMID:18765277 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PPARGC1A mRNA | CTD | PMID:16098508 |
| ethanol | decreases expression | ISO | RGD:1332548 | 6480464 | Ethanol results in decreased expression of PPARGC1A mRNA | CTD | PMID:18755807 PMID:20007851 |
| ethanol | multiple interactions | ISO | RGD:1332548 | 6480464 | [Ethanol results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein; more ... | CTD | PMID:18755807 |
| ethanol | multiple interactions | ISO | RGD:1332548 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in increased acetylation of PPARGC1A protein]; more ... | CTD | PMID:20007851 |
| ethanol | increases acetylation | ISO | RGD:1332548 | 6480464 | Ethanol results in increased acetylation of PPARGC1A protein | CTD | PMID:20007851 |
| ethanol | decreases expression | ISO | RGD:1332548 | 6480464 | Ethanol results in decreased expression of PPARGC1A mRNA | CTD | PMID:20007851 |
| fructose | decreases expression | ISO | RGD:1342674 | 6480464 | Fructose results in decreased expression of PPARGC1A mRNA | CTD | PMID:18063403 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of PPARGC1A mRNA | CTD | PMID:19196556 PMID:21212096 |
| fructose | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of PPARGC1A protein] | CTD | PMID:19196556 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of PPARGC1A protein; more ... | CTD | PMID:19196556 |
| glucose | increases acetylation | ISO | RGD:1342674 | 6480464 | Glucose results in increased acetylation of PPARGC1A protein | CTD | PMID:19071085 |
| glucose | multiple interactions | ISO | RGD:1332548 | 6480464 | AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; more ... | CTD | PMID:23090186 |
| glucose | decreases expression | ISO | RGD:1332548 | 6480464 | Glucose results in decreased expression of PPARGC1A protein | CTD | PMID:23090186 |
| glucose | multiple interactions | ISO | RGD:1342674 | 6480464 | Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA] | CTD | PMID:17855661 |
| glucose | decreases expression | ISO | RGD:1342674 | 6480464 | Glucose deficiency results in decreased expression of PPARGC1A mRNA | CTD | PMID:17855661 |
| glucose | multiple interactions | ISO | RGD:1342674 | 6480464 | [Pyruvic Acid co-treated with Glucose] results in decreased acetylation of PPARGC1A protein | CTD | PMID:19071085 |
| glutathione | increases expression | ISO | RGD:1342674 | 6480464 | Glutathione analog results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of PPARGC1A mRNA | CTD | PMID:21396975 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PPARGC1A mRNA | CTD | PMID:19808358 |
| kaempferol | increases expression | ISO | RGD:1342674 | 6480464 | kaempferol results in increased expression of PPARGC1A mRNA | CTD | PMID:17327447 |
| L-ascorbic acid | increases expression | ISO | RGD:1342674 | 6480464 | Ascorbic Acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| lauric acid | increases expression | ISO | RGD:1342674 | 6480464 | lauric acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| lipoic acid | multiple interactions | ISO | RGD:1342674 | 6480464 | [Acetylcarnitine co-treated with Thioctic Acid] results in increased expression of PPARGC1A protein | CTD | PMID:20414966 |
| lipoic acid | increases expression | ISO | RGD:1342674 | 6480464 | Thioctic Acid results in increased expression of PPARGC1A protein | CTD | PMID:20414966 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of PPARGC1A mRNA] | CTD | PMID:19109942 |
| losartan | increases expression | EXP | | 6480464 | Losartan results in increased expression of PPARGC1A mRNA | CTD | PMID:18765277 PMID:18971572 |
| losartan | increases expression | EXP | | 6480464 | Losartan results in increased expression of PPARGC1A mRNA | CTD | PMID:18971572 PMID:18765277 |
| losartan | increases expression | EXP | | 6480464 | Losartan results in increased expression of PPARGC1A mRNA | CTD | PMID:18765277 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein]; more ... | CTD | PMID:17179207 |
| malic acid | increases expression | ISO | RGD:1342674 | 6480464 | malic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| malonic acid | increases expression | ISO | RGD:1342674 | 6480464 | malonic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| metformin | increases expression | ISO | RGD:1342674 | 6480464 | Metformin results in increased expression of PPARGC1A mRNA | CTD | PMID:15864539 |
| metformin | multiple interactions | ISO | RGD:1332548 | 6480464 | Metformin inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein] | CTD | PMID:23090186 |
| metformin | multiple interactions | ISO | RGD:1332548 | 6480464 | Metformin inhibits the reaction [GCG protein results in increased expression of PPARGC1A mRNA]; more ... | CTD | PMID:22117073 |
| metformin | multiple interactions | ISO | RGD:1342674 | 6480464 | PRKAA1 protein affects the reaction [Metformin results in increased expression of PPARGC1A mRNA] | CTD | PMID:16380484 |
| metformin | increases expression | ISO | RGD:1342674 | 6480464 | Metformin results in increased expression of PPARGC1A mRNA | CTD | PMID:15864539 PMID:16380484 |
| metoprolol | multiple interactions | EXP | | 6480464 | Metoprolol inhibits the reaction [PPARGC1A protein binds to CPT1B promoter]; more ... | CTD | PMID:19233164 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1342674 | 6480464 | mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to PPARGC1A protein] | CTD | PMID:20123618 |
| myo-inositol hexakisphosphate | multiple interactions | ISO | RGD:1332548 | 6480464 | [resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | CTD | PMID:18657603 |
| myristic acid | increases expression | ISO | RGD:1342674 | 6480464 | Myristic Acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1342674 | 6480464 | Acetylcysteine inhibits the reaction [Flavonoids results in increased expression of PPARGC1A protein] | CTD | PMID:23063593 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with epigallocatechin gallate] results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:22742579 |
| nicotinamide | increases acetylation | ISO | RGD:1342674 | 6480464 | Niacinamide results in increased acetylation of PPARGC1A protein | CTD | PMID:19071085 |
| nicotinic acid | increases expression | ISO | RGD:1342674 | 6480464 | Niacin results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| nitroprusside | multiple interactions | ISO | RGD:1342674 | 6480464 | Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA] | CTD | PMID:17855661 |
| olanzapine | decreases expression | EXP | | 6480464 | olanzapine results in decreased expression of PPARGC1A mRNA | CTD | PMID:23226405 |
| olanzapine | multiple interactions | EXP | | 6480464 | olanzapine promotes the reaction [1-(carboxymethylthio)tetradecane results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:23226405 |
| oxaloacetic acid | increases expression | ISO | RGD:1342674 | 6480464 | Oxaloacetic Acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| palmitic acid | increases expression | ISO | RGD:1342674 | 6480464 | Palmitic Acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| palmitic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| paracetamol | affects expression | ISO | RGD:1332548 | 6480464 | Acetaminophen affects the expression of PPARGC1A mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | ISO | RGD:1332548 | 6480464 | Paraquat results in increased expression of PPARGC1A protein | CTD | PMID:22563483 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:1332548 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PPARGC1A mRNA | CTD | PMID:21705711 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:1332548 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PPARGC1A mRNA | CTD | PMID:20936131 PMID:21705711 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:19616056 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1332548 | 6480464 | perfluorooctanoic acid results in decreased expression of PPARGC1A mRNA | CTD | PMID:20936131 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1332548 | 6480464 | perfluorooctanoic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:22154759 |
| phenobarbital | increases expression | ISO | RGD:1332548 | 6480464 | Phenobarbital results in increased expression of PPARGC1A mRNA | CTD | PMID:19270015 |
| phenobarbital | decreases expression | ISO | RGD:1332548 | 6480464 | Phenobarbital results in decreased expression of PPARGC1A mRNA | CTD | PMID:23091169 |
| pirinixic acid | multiple interactions | ISO | RGD:1332548 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPARGC1A mRNA | CTD | PMID:19710929 |
| pirinixic acid | multiple interactions | ISO | RGD:1332548 | 6480464 | pirinixic acid promotes the reaction [PPARA protein binds to PPARGC1A protein] | CTD | PMID:20123618 |
| pirinixic acid | multiple interactions | ISO | RGD:1342674 | 6480464 | pirinixic acid promotes the reaction [PPARA protein binds to PPARGC1A protein] | CTD | PMID:20123618 |
| pirinixic acid | increases expression | ISO | RGD:1332548 | 6480464 | pirinixic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:17275789 PMID:18445702 |
| pirinixic acid | increases expression | ISO | RGD:1332548 | 6480464 | pirinixic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:18445702 PMID:17275789 |
| pirinixic acid | multiple interactions | ISO | RGD:1332548 | 6480464 | pirinixic acid promotes the reaction [PPARGC1B protein results in decreased expression of PPARGC1A mRNA] | CTD | PMID:17932310 |
| potassium chloride | increases expression | EXP | | 6480464 | Potassium Chloride results in increased expression of PPARGC1A protein; more ... | CTD | PMID:20438809 |
| potassium dichromate | increases expression | ISO | RGD:1342674 | 6480464 | Potassium Dichromate results in increased expression of PPARGC1A mRNA | CTD | PMID:18332044 |
| prazosin | multiple interactions | ISO | RGD:1332548 | 6480464 | [Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:1332548 | 6480464 | PPARGC1A protein promotes the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA]; more ... | CTD | PMID:21933665 |
| progesterone | multiple interactions | ISO | RGD:1342674 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of PPARGC1A mRNA | CTD | PMID:17404688 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| progesterone | increases expression | ISO | RGD:1342674 | 6480464 | Progesterone results in increased expression of PPARGC1A mRNA | CTD | PMID:17404688 PMID:23056435 |
| progesterone | increases expression | ISO | RGD:1342674 | 6480464 | Progesterone results in increased expression of PPARGC1A mRNA | CTD | PMID:17404688 |
| propiconazole | decreases expression | ISO | RGD:1332548 | 6480464 | propiconazole results in decreased expression of PPARGC1A mRNA | CTD | PMID:21278054 |
| propranolol | multiple interactions | ISO | RGD:1332548 | 6480464 | [Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| propranolol | multiple interactions | ISO | RGD:1332548 | 6480464 | Propranolol inhibits the reaction [Clenbuterol results in increased expression of PPARGC1A mRNA] | CTD | PMID:17446185 |
| propranolol | decreases expression | ISO | RGD:1332548 | 6480464 | Propranolol results in decreased expression of PPARGC1A mRNA | CTD | PMID:17446185 |
| prostaglandin D2 | increases expression | ISO | RGD:1342674 | 6480464 | Prostaglandin D2 results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| prostaglandin I2 | increases expression | ISO | RGD:1342674 | 6480464 | Epoprostenol results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| pyridaben | increases expression | ISO | RGD:1332548 | 6480464 | pyridaben results in increased expression of PPARGC1A mRNA | CTD | PMID:22563483 |
| pyridoxine | increases expression | ISO | RGD:1342674 | 6480464 | Pyridoxine results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| pyridoxine | increases expression | EXP | | 6480464 | Pyridoxine results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| pyruvic acid | multiple interactions | ISO | RGD:1342674 | 6480464 | [Pyruvic Acid co-treated with Glucose] results in decreased acetylation of PPARGC1A protein | CTD | PMID:19071085 |
| pyruvic acid | multiple interactions | ISO | RGD:1332548 | 6480464 | SIRT1 mRNA affects the reaction [Pyruvic Acid inhibits the reaction [PPARGC1A protein promotes the reaction [Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA]]] | CTD | PMID:21933665 |
| quercetin | increases expression | ISO | RGD:1332548 | 6480464 | Quercetin results in increased expression of PPARGC1A mRNA | CTD | PMID:19211721 |
| quercetin | decreases expression | ISO | RGD:1342674 | 6480464 | Quercetin results in decreased expression of PPARGC1A mRNA | CTD | PMID:21632981 |
| quercetin | multiple interactions | ISO | RGD:1332548 | 6480464 | [resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | CTD | PMID:18657603 |
| resveratrol | increases expression | ISO | RGD:1342674 | 6480464 | resveratrol results in increased expression of PPARGC1A | CTD | PMID:21224254 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARGC1A mRNA] | CTD | PMID:21632075 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:20438809 PMID:21715682 |
| resveratrol | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased expression of PPARGC1A mRNA] | CTD | PMID:20438809 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | [SIRT1 protein co-treated with resveratrol] affects the reaction [Glucose affects the expression of PPARGC1A protein] | CTD | PMID:23090186 |
| resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:22878646 PMID:23090186 |
| resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:17438283 PMID:22878646 |
| resveratrol | decreases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased expression of PPARGC1A protein modified form | CTD | PMID:23090186 |
| resveratrol | affects response to substance | ISO | RGD:1332548 | 6480464 | PPARGC1A protein affects the susceptibility to resveratrol | CTD | PMID:23090186 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | resveratrol inhibits the reaction [[Ethanol results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein]; more ... | CTD | PMID:18755807 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of PPARGC1A protein | CTD | PMID:20561979 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARGC1A protein] | CTD | PMID:22610192 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:20429690 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:20438809 more ... |
| resveratrol | decreases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased expression of PPARGC1A mRNA | CTD | PMID:21270273 |
| resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:17438283 more ... |
| resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A | CTD | PMID:21224254 |
| resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:17438283 |
| resveratrol | increases activity | ISO | RGD:1332548 | 6480464 | resveratrol results in increased activity of PPARGC1A protein | CTD | PMID:17086191 |
| resveratrol | decreases acetylation | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased acetylation of PPARGC1A protein | CTD | PMID:17581637 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | resveratrol promotes the reaction [SIRT1 protein results in decreased acetylation of PPARGC1A protein] | CTD | PMID:17581637 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased acetylation of and results in increased activity of PPARGC1A protein | CTD | PMID:17112576 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | [resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | CTD | PMID:18657603 |
| resveratrol | increases expression | ISO | RGD:1342674 | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:16849586 |
| resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | SIRT1 protein promotes the reaction [resveratrol results in increased expression of PPARGC1A mRNA] | CTD | PMID:19934007 |
| resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:22610192 more ... |
| riboflavin | increases expression | ISO | RGD:1342674 | 6480464 | Riboflavin results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| rifampicin | multiple interactions | ISO | RGD:1342674 | 6480464 | Rifampin promotes the reaction [PPARGC1A protein binds to CYP2A6 promoter] | CTD | PMID:16857725 |
| rifampicin | multiple interactions | ISO | RGD:1342674 | 6480464 | Rifampin promotes the reaction [PPARGC1A protein binds to HNF4A protein] | CTD | PMID:21292004 |
| rosiglitazone | increases expression | ISO | RGD:1342674 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 |
| rosiglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A mRNA] | CTD | PMID:21113404 |
| rosiglitazone | increases expression | ISO | RGD:1332548 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:15520860 more ... |
| rosiglitazone | increases expression | ISO | RGD:1342674 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:15864539 more ... |
| rosiglitazone | increases expression | ISO | RGD:1332548 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 more ... |
| rosiglitazone | increases expression | ISO | RGD:1342674 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:17310221 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | PPARGC1A protein promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 PMID:16513826 |
| rosiglitazone | increases expression | ISO | RGD:1342674 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 more ... |
| rosiglitazone | decreases expression | ISO | RGD:1332548 | 6480464 | rosiglitazone results in decreased expression of PPARGC1A mRNA | CTD | PMID:17361034 |
| rosiglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | rosiglitazone inhibits the reaction [Dietary Fats results in decreased expression of PPARGC1A mRNA] | CTD | PMID:17456854 |
| rosiglitazone | affects expression | ISO | RGD:1332548 | 6480464 | rosiglitazone affects the expression of PPARGC1A mRNA | CTD | PMID:22013433 |
| rosiglitazone | increases expression | ISO | RGD:1342674 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:17310221 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:21373642 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | SIRT6 affects the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | CTD | PMID:21373642 |
| rosiglitazone | increases expression | ISO | RGD:1332548 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:22087241 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARGC1A mRNA]; more ... | CTD | PMID:20007851 |
| rosiglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | PPARGC1A affects the reaction [rosiglitazone results in increased expression of COX8B mRNA]; more ... | CTD | PMID:22087241 |
| rosiglitazone | affects response to substance | ISO | RGD:1342674 | 6480464 | PPARGC1A gene polymorphism affects the susceptibility to rosiglitazone | CTD | PMID:20498286 |
| rosiglitazone | increases expression | ISO | RGD:1332548 | 6480464 | rosiglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 PMID:15520860 |
| rosiglitazone | increases expression | ISO | RGD:1332548 | 6480464 | rosiglitazone results in increased expression of PPARGC1A protein | CTD | PMID:16513826 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of PPARGC1A protein] | CTD | PMID:19196556 |
| rosiglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA]; more ... | CTD | PMID:16513826 |
| S-adenosyl-L-homocysteine | increases expression | ISO | RGD:1342674 | 6480464 | S-Adenosylhomocysteine results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| salmeterol | increases expression | ISO | RGD:1332548 | 6480464 | salmeterol results in increased expression of PPARGC1A mRNA | CTD | PMID:17446185 |
| stearic acid | increases expression | ISO | RGD:1342674 | 6480464 | stearic acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| streptozocin | decreases expression | ISO | RGD:1332548 | 6480464 | Streptozocin results in decreased expression of PPARGC1A protein | CTD | PMID:21381899 |
| streptozocin | multiple interactions | ISO | RGD:1332548 | 6480464 | telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARGC1A protein] | CTD | PMID:21381899 |
| tamoxifen | multiple interactions | ISO | RGD:1342674 | 6480464 | Tamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein] | CTD | PMID:16889744 |
| telmisartan | multiple interactions | ISO | RGD:1332548 | 6480464 | telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARGC1A protein] | CTD | PMID:21381899 |
| tert-butyl hydroperoxide | decreases response to substance | ISO | RGD:1332548 | 6480464 | PPARGC1A protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:17460188 |
| testosterone | multiple interactions | EXP | | 6480464 | Norepinephrine inhibits the reaction [Testosterone results in decreased expression of PPARGC1A mRNA] | CTD | PMID:16954335 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PPARGC1A protein] | CTD | PMID:21094144 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of PPARGC1A mRNA | CTD | PMID:16954335 |
| testosterone | increases expression | ISO | RGD:1332548 | 6480464 | Testosterone results in increased expression of PPARGC1A mRNA | CTD | PMID:21045173 |
| trans-resveratrol | increases expression | ISO | RGD:1342674 | 6480464 | resveratrol results in increased expression of PPARGC1A | CTD | PMID:21224254 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARGC1A mRNA] | CTD | PMID:21632075 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA; more ... | CTD | PMID:20438809 PMID:21715682 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in increased expression of PPARGC1A mRNA] | CTD | PMID:20438809 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | [SIRT1 protein co-treated with resveratrol] affects the reaction [Glucose affects the expression of PPARGC1A protein] | CTD | PMID:23090186 |
| trans-resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:22878646 PMID:23090186 |
| trans-resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:17438283 PMID:22878646 |
| trans-resveratrol | affects response to substance | ISO | RGD:1332548 | 6480464 | PPARGC1A protein affects the susceptibility to resveratrol | CTD | PMID:23090186 |
| trans-resveratrol | decreases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased expression of PPARGC1A protein modified form | CTD | PMID:23090186 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | resveratrol inhibits the reaction [[Ethanol results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein]; more ... | CTD | PMID:18755807 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in increased expression of PPARGC1A protein | CTD | PMID:20561979 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:20438809 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:20429690 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARGC1A protein] | CTD | PMID:22610192 |
| trans-resveratrol | decreases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased expression of PPARGC1A mRNA | CTD | PMID:21270273 |
| trans-resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:17438283 more ... |
| trans-resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A | CTD | PMID:21224254 |
| trans-resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A mRNA | CTD | PMID:17438283 |
| trans-resveratrol | increases activity | ISO | RGD:1332548 | 6480464 | resveratrol results in increased activity of PPARGC1A protein | CTD | PMID:17086191 |
| trans-resveratrol | decreases acetylation | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased acetylation of PPARGC1A protein | CTD | PMID:17581637 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | resveratrol promotes the reaction [SIRT1 protein results in decreased acetylation of PPARGC1A protein] | CTD | PMID:17581637 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | resveratrol results in decreased acetylation of and results in increased activity of PPARGC1A protein | CTD | PMID:17112576 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | [resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | CTD | PMID:18657603 |
| trans-resveratrol | increases expression | ISO | RGD:1342674 | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:16849586 |
| trans-resveratrol | multiple interactions | ISO | RGD:1332548 | 6480464 | SIRT1 protein promotes the reaction [resveratrol results in increased expression of PPARGC1A mRNA] | CTD | PMID:19934007 |
| trans-resveratrol | increases expression | ISO | RGD:1332548 | 6480464 | resveratrol results in increased expression of PPARGC1A protein | CTD | PMID:22610192 more ... |
| troglitazone | multiple interactions | ISO | RGD:1332548 | 6480464 | PPARG protein promotes the reaction [troglitazone results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:14563825 |
| troglitazone | increases expression | ISO | RGD:1342674 | 6480464 | troglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:20860658 |
| troglitazone | increases degradation | ISO | RGD:1342674 | 6480464 | troglitazone results in increased degradation of PPARGC1A protein | CTD | PMID:20860658 |
| troglitazone | decreases expression | ISO | RGD:1342674 | 6480464 | troglitazone results in decreased expression of PPARGC1A protein | CTD | PMID:20860658 |
| troglitazone | multiple interactions | ISO | RGD:1342674 | 6480464 | PPARGC1A protein inhibits the reaction [troglitazone results in decreased expression of TFAM mRNA]; more ... | CTD | PMID:20860658 |
| troglitazone | decreases response to substance | ISO | RGD:1342674 | 6480464 | PPARGC1A protein results in decreased susceptibility to troglitazone | CTD | PMID:20860658 |
| troglitazone | increases expression | ISO | RGD:1332548 | 6480464 | troglitazone results in increased expression of PPARGC1A mRNA | CTD | PMID:16513826 |
| tunicamycin | increases expression | ISO | RGD:1332548 | 6480464 | Tunicamycin results in increased expression of PPARGC1A mRNA | CTD | PMID:22414386 |
| UDP-alpha-D-glucuronic acid | increases expression | ISO | RGD:1342674 | 6480464 | Uridine Diphosphate Glucuronic Acid results in increased expression of PPARGC1A mRNA | CTD | PMID:23056435 |
| vancomycin | increases expression | ISO | RGD:1332548 | 6480464 | Vancomycin results in increased expression of PPARGC1A mRNA | CTD | PMID:18930951 |